Bob Tepper, M.D., R&D president, is leaving Millennium in the first quarter of 2007. Dr. Tepper was one of the founding executives in 1994 and was an integral part of its expansion from a drug discovery company to a fully-integrated biopharmaceutical company with nine novel molecules in development and market-leading product, Velcade for Injection for relapsed multiple myeloma and mantle cell lymphoma. “Bob was one of a small group of people who had a vision for forming a new com...